Works by Turecek, Peter

Results: 37

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease.

Published in:

Journal of Blood Medicine, 2022, v. 13, p. 649, doi. 10.2147/JBM.S377126

By:

Gritsch, Herbert;
Schrenk, Gerald;
Weinhappl, Nina;
Mellgård, Björn;
Ewenstein, Bruce;
Turecek, Peter L

Publication type:

Article

Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.

Published in:

Platelets, 2019, v. 30, n. 2, p. 264, doi. 10.1080/09537104.2017.1420153

By:

Pekrul, Isabell;
Kragh, Thorsten;
Spannagl, Michael;
Turecek, Peter L;
Novack, Aaron R;
Ott, Helmut W

Publication type:

Article

Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B.

Published in:

International Journal of Hematology, 2013, v. 98, n. 5, p. 525, doi. 10.1007/s12185-013-1448-z

By:

Dietrich, Barbara;
Schiviz, Alexandra;
Hoellriegl, Werner;
Horling, Frank;
Benamara, Karima;
Rottensteiner, Hanspeter;
Turecek, Peter L.;
Schwarz, Hans Peter;
Scheiflinger, Friedrich;
Muchitsch, Eva-Maria

Publication type:

Article

A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2010, v. 24, n. 6, p. 761, doi. 10.1002/rcm.4440

By:

Kemptner, Jasmin;
Marchetti-Deschmann, Martina;
Müller, Roland;
Ivens, Andreas;
Turecek, Peter;
Schwarz, Hans Peter;
Allmaier, Günter

Publication type:

Article

Comprehensive glyco-proteomic analysis of human α1-antitrypsin and its charge isoforms.

Published in:

Proteomics, 2006, v. 6, n. 11, p. 3369, doi. 10.1002/pmic.200500751

By:

Daniel Kolarich;
Alfred Weber;
Peter L. Turecek;
Hans-Peter Schwarz;
Friedrich Altmann

Publication type:

Article

In vivo and in vitro processing of recombinant pro-von Willebrand factor.

Published in:

Histochemistry & Cell Biology, 2002, v. 117, n. 2, p. 123, doi. 10.1007/s00418-001-0375-x

By:

Turecek, Peter L.;
Váradi, Katalin;
Schlokat, Uwe;
Pichler, Ludwig;
Dorner, Friedrich;
Schwarz, Hans Peter

Publication type:

Article

Polyethylene Glycol Exposure with Antihemophilic Factor (Recombinant), PEGylated (rurioctocog alfa pegol) and Other Therapies Indicated for the Pediatric Population: History and Safety.

Published in:

Pharmaceuticals (14248247), 2018, v. 11, n. 3, p. 75, doi. 10.3390/ph11030075

By:

Stidl, Reinhard;
Denne, Michael;
Goldstine, Jimena;
Kadish, Bill;
Korakas, Katherine I.;
Turecek, Peter L.

Publication type:

Article

PEGylated Biopharmaceuticals.

Published in:

Toxicologic Pathology, 2015, v. 43, n. 7, p. 959, doi. 10.1177/0192623315591171

By:

Ivens, Inge A.;
Achanzar, William;
Baumann, Andreas;
Brändli-Baiocco, Annamaria;
Cavagnaro, Joy;
Dempster, Maggie;
Depelchin, B. Olympe;
Irizarry Rovira, Armando R.;
Dill-Morton, Laura;
Lane, Joan H.;
Reipert, Birgit M.;
Salcedo, Theodora;
Schweighardt, Becky;
Tsuruda, Laurie S.;
Turecek, Peter L.;
Sims, Jennifer

Publication type:

Article

Mutation of the surface-exposed amino acid Trp2313 to Ala in the FVIII C2 domain results in defective secretion of the otherwise functional protein.

Published in:

British Journal of Haematology, 2004, v. 125, n. 5, p. 629, doi. 10.1111/j.1365-2141.2004.04959.x

By:

Schatz, Simone M.;
Zimmermann, Klaus;
Hasslacher, Meinhard;
Kerschbaumer, Randolf;
Dockal, Michael;
Gritsch, Herbert;
Turecek, Peter L.;
Schwarz, Hans P.;
Dorner, Friedrich;
Scheiflinger, Friedrich

Publication type:

Article

SHORT REPORT Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse model.

Published in:

British Journal of Haematology, 2003, v. 123, n. 4, p. 692, doi. 10.1046/j.1365-2141.2003.04674.x

By:

Schatz, Simone;
Turecek, Peter L.;
Fiedler, Christian;
Zimmermann, Klaus;
Gritsch, Herbert;
Voorberg, Jan;
Schwarz, Hans Peter;
Dorner, Friedrich;
Scheiflinger, Friedrich

Publication type:

Article

Activation and inactivation of human factor X by proteases derived from Ficus carica.

Published in:

British Journal of Haematology, 2002, v. 119, n. 4, p. 1042, doi. 10.1046/j.1365-2141.2002.03954.x

By:

Richter, Günter;
Schwarz, Hans Peter;
Dorner, Friedrich;
Turecek, Peter L.

Publication type:

Article

A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein Solutions.

Published in:

Pharmaceutical Research, 2015, v. 32, n. 9, p. 2863, doi. 10.1007/s11095-015-1669-3

By:

Lubich, Christian;
Malisauskas, Mantas;
Prenninger, Thomas;
Wurz, Thomas;
Matthiessen, Peter;
Turecek, Peter;
Scheiflinger, Friedrich;
Reipert, Birgit

Publication type:

Article

Factor Xa and Prothrombin: Mechanism of Action of FEIBA.

Published in:

Vox Sanguinis, 1999, v. 77, p. 72, doi. 10.1111/j.1423-0410.1999.tb00020.x

By:

Turecek, Peter L.;
Varadi, Katalin;
Gritsch, Herbert;
Auer, Wilfried;
Pichler, Ludwig;
Eder, Gerald;
Schwarz, Hans Peter

Publication type:

Article

Factor Xa and Prothrombin: Mechanism of Action of FEIBA.

Published in:

Vox Sanguinis, 1999, v. 77, p. 72, doi. 10.1159/000056722

By:

Turecek, Peter L.;
Varadi, Katalin;
Gritsch, Herbert;
Auer, Wilfried;
Pichler, Ludwig;
Eder, Gerald;
Schwarz, Hans Peter

Publication type:

Article

Effect of High- versus Intermediate-Purity Blood Coagulation Factor Concentrates on HIV-1 Replication.

Published in:

Vox Sanguinis, 1996, v. 70, n. 4, p. 195, doi. 10.1111/j.1423-0410.1996.tb01325.x

By:

Schögl, Daniela;
Zimmermann, Klaus;
Turecek, Peter L.;
Schwarz, Hans Peter;
Eibl, Martha M.;
Mannhalter, Josef W.

Publication type:

Article

Proteomic analysis of UVC irradiation-induced damage of plasma proteins: Serum amyloid P component as a major target of photolysis

Published in:

FEBS Letters, 2006, v. 580, n. 13, p. 3229, doi. 10.1016/j.febslet.2006.05.002

By:

Chan, Hong-Lin;
Gaffney, Piers R.;
Waterfield, Michael D.;
Anderle, Heinz;
Peter Matthiessen, H.;
Schwarz, Hans-Peter;
Turecek, Peter L.;
Timms, John F.

Publication type:

Article

Reply.

Published in:

2001

By:

Völkel, Dirk;
Zimmermann, Klaus;
Zerr, Inga;
Bodemer, Monica;
Linder, Thomas;
Turecek, Peter L.;
Poser, Sigrid;
Schwarz, Hans Peter

Publication type:

Letter

Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases.

Published in:

2001

By:

Völkel, Dirk;
Zimmermann, Klaus;
Zerr, Inga;
Bodemer, Monica;
Lindner, Thomas;
Turecek, Peter L.;
Poser, Sigrid;
Schwarz, Hans P.;
Völkel, D;
Zimmermann, K;
Zerr, I;
Bodemer, M;
Lindner, T;
Turecek, P L;
Poser, S;
Schwarz, H P

Publication type:

journal article

In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma‐derived von Willebrand factor products.

Published in:

Haemophilia, 2024, v. 30, n. 1, p. 151, doi. 10.1111/hae.14892

By:

Turecek, Peter L.;
Ilk, Reinhard;
Gritsch, Herbert

Publication type:

Article

A cross‐sectional follow‐up study of physical activity in adults with moderate and severe haemophilia.

Published in:

Haemophilia, 2023, v. 29, n. 3, p. 892, doi. 10.1111/hae.14775

By:

Kennedy, Megan;
Roche, Sheila;
McGowan, Mark;
Larkin, Niamh;
O'Connell, Niamh M.;
O'Mahony, Brian;
Lavin, Michelle;
O'Donnell, James S.;
Turecek, Peter L.;
Gormley, John

Publication type:

Article

Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia.

Published in:

Haemophilia, 2023, v. 29, n. 1, p. 72, doi. 10.1111/hae.14653

By:

Kennedy, Megan;
Roche, Sheila;
McGowan, Mark;
Singleton, Evelyn;
Elsheikh, Einas;
O'Donovan, Mairead;
Ryan, Kevin;
O'Connell, Niamh M.;
O'Mahony, Brian;
Lavin, Michelle;
O'Donnell, James S.;
Turecek, Peter L.;
Gormley, John

Publication type:

Article

A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen.

Published in:

Haemophilia, 2021, v. 27, n. 4, p. 544, doi. 10.1111/hae.14282

By:

Kennedy, Megan;
O'Gorman, Philip;
Monaghan, Ann;
Lavin, Michelle;
O'Mahony, Brian;
O'Connell, Niamh M.;
O' Donnell, James S.;
Turecek, Peter L.;
Gormley, John

Publication type:

Article

Biological mechanisms underlying inter‐individual variation in factor VIII clearance in haemophilia.

Published in:

Haemophilia, 2020, v. 26, n. 4, p. 575, doi. 10.1111/hae.14078

By:

Turecek, Peter L.;
Johnsen, Jill M.;
Pipe, Steven W.;
O'Donnell, James S.

Publication type:

Article

Ethanol dependence of α1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases.

Published in:

Transfusion, 2008, v. 48, n. 2, p. 314, doi. 10.1111/j.1537-2995.2007.01525.x

By:

Matthiessen, H. Peter;
Willemse, Johan;
Weber, Alfred;
Turecek, Peter L.;
Deiteren, Kathleen;
Hendriks, Dirk;
Ehrlich, Hartmut J.;
Schwarz, Hans-Peter

Publication type:

Article

Biochemical, molecular characterization, and glycoproteomic analyses of α1-proteinase inhibitor products used for replacement therapy.

Published in:

Transfusion, 2006, v. 46, n. 11, p. 1959, doi. 10.1111/j.1537-2995.2006.01004.x

By:

Kolarich, Daniel;
Turecek, Peter L.;
Weber, Alfred;
Mitterer, Artur;
Graninger, Michael;
Matthiessen, Peter;
Nicolaes, Gerry A.F.;
Altmann, Friedrich;
Schwarz, Hans Peter

Publication type:

Article

Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry.

Published in:

Vox Sanguinis, 2022, v. 117, n. 6, p. 780, doi. 10.1111/vox.13267

By:

Turecek, Peter L.;
Hibbett, Deborah;
Kreil, Thomas R.

Publication type:

Article

Reply to Farrugia: Appropriately specifying the quality of plasma for fractionation.

Published in:

Vox Sanguinis, 2022, v. 117, n. 3, p. 460, doi. 10.1111/vox.13185

By:

Siekmann, Jürgen;
Weber, Alfred;
Bauer, Christoph;
Turecek, Peter L.

Publication type:

Article

Biochemical and cellular markers differentiate recovered, in‐line filtered plasma, and plasma obtained by apheresis methods.

Published in:

Vox Sanguinis, 2022, v. 117, n. 1, p. 27, doi. 10.1111/vox.13118

By:

Siekmann, Jürgen;
Weber, Alfred;
Bauer, Christoph;
Turecek, Peter L.

Publication type:

Article

Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE.

Published in:

Electrophoresis, 2011, v. 32, n. 11, p. 1292, doi. 10.1002/elps.201000627

By:

Monetti, Christina;
Rottensteiner, Hanspeter;
Gritsch, Herbert;
Weber, Alfred;
Scheiflinger, Friedrich;
Turecek, Peter L.

Publication type:

Article

Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE.

Published in:

Proteomics - Clinical Applications, 2011, v. 5, n. 9/10, p. 573, doi. 10.1002/prca.201190095

By:

Monetti, Christina;
Rottensteiner, Hanspeter;
Gritsch, Herbert;
Weber, Alfred;
Scheiflinger, Friedrich;
Turecek, Peter L.

Publication type:

Article

Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes.

Published in:

Expert Review of Clinical Pharmacology, 2015, v. 8, n. 2, p. 163, doi. 10.1586/17512433.2015.1011126

By:

Turecek, Peter L;
Abbühl, Brigitt;
Tangada, Srilatha D;
Chapman, Miranda;
Gritsch, Herbert;
Rottensteiner, Hanspeter;
Schrenk, Gerald;
Mitterer, Artur;
Dietrich, Barbara;
Höllriegl, Werner;
Schiviz, Alexandra;
Horling, Frank;
Reipert, Birgit M;
Muchitsch, Eva-Maria;
Pavlova, Borislava G;
Scheiflinger, Friedrich

Publication type:

Article

Microchip capillary gel electrophoresis of multiply PEGylated high-molecular-mass glycoproteins.

Published in:

Biotechnology Journal, 2012, v. 7, n. 5, p. 635, doi. 10.1002/biot.201100407

By:

Seyfried, Birgit K.;
Marchetti-Deschmann, Martina;
Siekmann, Jürgen;
Bossard, Mary J.;
Scheiflinger, Friedrich;
Turecek, Peter L.;
Allmaier, Günter

Publication type:

Article

Ca concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopy.

Published in:

Analytical & Bioanalytical Chemistry, 2015, v. 407, n. 20, p. 6051, doi. 10.1007/s00216-015-8778-z

By:

Bonazza, Klaus;
Rottensteiner, Hanspeter;
Schrenk, Gerald;
Fiedler, Christian;
Scheiflinger, Friedrich;
Allmaier, Günter;
Turecek, Peter;
Friedbacher, Gernot

Publication type:

Article

Visualization of a protein-protein interaction at a single-molecule level by atomic force microscopy.

Published in:

Analytical & Bioanalytical Chemistry, 2014, v. 406, n. 5, p. 1411, doi. 10.1007/s00216-013-7563-0

By:

Bonazza, Klaus;
Rottensteiner, Hanspeter;
Seyfried, Birgit;
Schrenk, Gerald;
Allmaier, Günter;
Turecek, Peter;
Friedbacher, Gernot

Publication type:

Article

Genotyping of the prion protein gene at codon 129.

Published in:

Acta Neuropathologica, 1999, v. 97, n. 4, p. 355, doi. 10.1007/s004010050998

By:

Zimmermann, Klaus;
Turecek, Peter L.;
Schwarz, Hans Peter

Publication type:

Article

Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.894411

By:

Schoenbrunn, Anne;
Juelke, Kerstin;
Reipert, Birgit M.;
Horling, Frank;
Turecek, Peter L.

Publication type:

Article

Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study.

Published in:

European Journal of Haematology, 2022, v. 108, n. 6, p. 518, doi. 10.1111/ejh.13763

By:

Kennedy, Megan;
O' Mahony, Brian;
Roche, Sheila;
McGowan, Mark;
Singleton, Evelyn;
Ryan, Kevin;
O' Connell, Niamh M.;
Pipe, Steven W.;
Lavin, Michelle;
O' Donnell, James S.;
Turecek, Peter L.;
Gormley, John

Publication type:

Article

Works by Turecek, Peter

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease.

Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.

Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B.

A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor

Comprehensive glyco-proteomic analysis of human α1-antitrypsin and its charge isoforms.

In vivo and in vitro processing of recombinant pro-von Willebrand factor.

Polyethylene Glycol Exposure with Antihemophilic Factor (Recombinant), PEGylated (rurioctocog alfa pegol) and Other Therapies Indicated for the Pediatric Population: History and Safety.

PEGylated Biopharmaceuticals.

Mutation of the surface-exposed amino acid Trp<sup>2313</sup> to Ala in the FVIII C2 domain results in defective secretion of the otherwise functional protein.

SHORT REPORT Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse model.

Activation and inactivation of human factor X by proteases derived from Ficus carica.

A Flow-Cytometry-Based Approach to Facilitate Quantification, Size Estimation and Characterization of Sub-visible Particles in Protein Solutions.

Factor Xa and Prothrombin: Mechanism of Action of FEIBA.

Factor Xa and Prothrombin: Mechanism of Action of FEIBA.

Effect of High- versus Intermediate-Purity Blood Coagulation Factor Concentrates on HIV-1 Replication.

Proteomic analysis of UVC irradiation-induced damage of plasma proteins: Serum amyloid P component as a major target of photolysis

Reply.

Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases.

In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma‐derived von Willebrand factor products.

A cross‐sectional follow‐up study of physical activity in adults with moderate and severe haemophilia.

Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia.

A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen.

Biological mechanisms underlying inter‐individual variation in factor VIII clearance in haemophilia.

Ethanol dependence of α<sub>1</sub>-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases.

Biochemical, molecular characterization, and glycoproteomic analyses of α<sub>1</sub>-proteinase inhibitor products used for replacement therapy.

Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry.

Reply to Farrugia: Appropriately specifying the quality of plasma for fractionation.

Biochemical and cellular markers differentiate recovered, in‐line filtered plasma, and plasma obtained by apheresis methods.

Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE.

Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE.

Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes.

Microchip capillary gel electrophoresis of multiply PEGylated high-molecular-mass glycoproteins.

Ca concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopy.

Visualization of a protein-protein interaction at a single-molecule level by atomic force microscopy.

Genotyping of the prion protein gene at codon 129.

Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages.

Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study.